Peer Review reports
From: Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer
Original Submission | ||
---|---|---|
14 Jun 2021 | Submitted | Original manuscript |
24 Jul 2021 | Reviewed | Reviewer Report - Tadahiko Shien |
18 Nov 2021 | Reviewed | Reviewer Report |
3 Dec 2021 | Author responded | Author comments - Anjana Bhardwaj |
Resubmission - Version 2 | ||
3 Dec 2021 | Submitted | Manuscript version 2 |
10 Dec 2021 | Author responded | Author comments - Anjana Bhardwaj |
Resubmission - Version 3 | ||
10 Dec 2021 | Submitted | Manuscript version 3 |
22 Dec 2021 | Author responded | Author comments - Anjana Bhardwaj |
Resubmission - Version 4 | ||
22 Dec 2021 | Submitted | Manuscript version 4 |
20 Jan 2022 | Author responded | Author comments - Anjana Bhardwaj |
Resubmission - Version 5 | ||
20 Jan 2022 | Submitted | Manuscript version 5 |
1 Feb 2022 | Author responded | Author comments - Anjana Bhardwaj |
Resubmission - Version 6 | ||
1 Feb 2022 | Submitted | Manuscript version 6 |
22 Feb 2022 | Author responded | Author comments - Anjana Bhardwaj |
Resubmission - Version 7 | ||
22 Feb 2022 | Submitted | Manuscript version 7 |
Publishing | ||
28 Feb 2022 | Editorially accepted | |
17 Mar 2022 | Article published | 10.1186/s12885-022-09353-2 |
You can find further information about peer review here.